Central Drugs Standard Control Organisation
E574393
drug regulatory agency
government agency of India
medical device regulatory agency
national regulatory authority
The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Central Drugs Standard Control Organisation canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T6162586 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Central Drugs Standard Control Organisation Context triple: [Ministry of Health and Family Welfare (India), oversees, Central Drugs Standard Control Organisation]
-
A.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
B.
Bureau of Drug Abuse Control
The Bureau of Drug Abuse Control was a U.S. federal agency in the 1960s responsible for enforcing laws against the illegal use and distribution of certain drugs, later merged into the Bureau of Narcotics and Dangerous Drugs.
-
C.
STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
-
D.
Commission on Narcotic Drugs
The Commission on Narcotic Drugs is a United Nations policy-making body responsible for overseeing international drug control and shaping global strategies to address narcotic drugs and related issues.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Central Drugs Standard Control Organisation Target entity description: The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
-
A.
Centre for Drug Safety
The Centre for Drug Safety is a specialized unit within the Norwegian Institute of Public Health that focuses on monitoring, researching, and improving the safe use of medicines.
-
B.
Bureau of Drug Abuse Control
The Bureau of Drug Abuse Control was a U.S. federal agency in the 1960s responsible for enforcing laws against the illegal use and distribution of certain drugs, later merged into the Bureau of Narcotics and Dangerous Drugs.
-
C.
STC on Health, Population and Drug Control
The STC on Health, Population and Drug Control is an African Union specialized technical committee responsible for guiding and coordinating continental policies and programs on public health, population issues, and drug regulation and control.
-
D.
Commission on Narcotic Drugs
The Commission on Narcotic Drugs is a United Nations policy-making body responsible for overseeing international drug control and shaping global strategies to address narcotic drugs and related issues.
-
E.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
- F. None of above. chosen
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
drug regulatory agency
ⓘ
government agency of India ⓘ medical device regulatory agency ⓘ national regulatory authority ⓘ |
| aimsTo |
ensure efficacy of drugs
ⓘ
ensure quality of drugs ⓘ ensure safety of drugs ⓘ |
| collaboratesWith |
World Health Organization
NERFINISHED
ⓘ
state drug control organisations in India ⓘ |
| country | India ⓘ |
| hasPart | Drugs Controller General of India office NERFINISHED ⓘ |
| headquartersLocation |
New Delhi, India
ⓘ
surface form:
New Delhi
|
| issues |
licences for import of drugs
ⓘ
licences for manufacture of certain categories of drugs ⓘ marketing authorisations for drugs ⓘ |
| jurisdiction | Republic of India NERFINISHED ⓘ |
| languageOfWork |
English
ⓘ
Hindi ⓘ |
| legalBasis |
Drugs and Cosmetics Act, 1940
NERFINISHED
ⓘ
Drugs and Cosmetics Rules, 1945 NERFINISHED ⓘ |
| oversees | Central Licence Approving Authority functions ⓘ |
| parentOrganisation |
Directorate General of Health Services
NERFINISHED
ⓘ
Ministry of Health and Family Welfare NERFINISHED ⓘ |
| regulates |
cosmetic manufacturers
ⓘ
importers of drugs ⓘ manufacturers of medical devices ⓘ pharmaceutical companies in India ⓘ |
| responsibleFor |
approval of new drugs
ⓘ
clinical trial approvals ⓘ licensing of drug import ⓘ licensing of drug manufacturing ⓘ oversight of drug quality ⓘ pharmacovigilance oversight ⓘ post-marketing surveillance of drugs ⓘ regulation of biological products ⓘ regulation of blood and blood products ⓘ regulation of cosmetics ⓘ regulation of drugs ⓘ regulation of medical devices ⓘ regulation of notified medical devices ⓘ regulation of vaccines ⓘ |
| sector |
cosmetics regulation
ⓘ
medical device regulation ⓘ pharmaceutical regulation ⓘ public health ⓘ |
| shortName | CDSCO NERFINISHED ⓘ |
| website | https://cdsco.gov.in ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Central Drugs Standard Control Organisation Description of subject: The Central Drugs Standard Control Organisation is India’s national regulatory authority responsible for approving, licensing, and overseeing the safety, efficacy, and quality of drugs, medical devices, and cosmetics.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
Ministry of Health and Family Welfare (India)
→
oversees
→
Central Drugs Standard Control Organisation
ⓘ